Institutional Ownership Vera Therapeutics, Inc. (VERA)
This table provides information about the institutional ownership of Vera Therapeutics, Inc. (VERA). We have compiled data on the 199 institutions that hold shares in the stock, with a total of 64.6 Million shares, which have been reported (via 13F filing form) to have a value of $1.37 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Avoro Capital Advisors LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
6,300,000
shares
|
$133 Million
2.71% of portfolio
|
Q2 2025
Added 10.49%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
4,479,717
shares
|
$94.7 Million
0.01% of portfolio
|
Q2 2025
Reduced 5.79%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Aug 14, 2025 Q2 2025 |
3,426,887
shares
|
$72.4 Million
9.64% of portfolio
|
Q2 2025
Added 42.79%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Aug 14, 2025 Q2 2025 |
3,348,117
shares
|
$70.8 Million
1.81% of portfolio
|
Q2 2025
Added 218.87%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,337,672
shares
|
$70.6 Million
0.0% of portfolio
|
Q2 2024
Added 0.56%
|
|
|
Vestal Point Capital, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
3,100,000
shares
|
$65.5 Million
3.85% of portfolio
|
Q2 2025
Added 24.0%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
3,001,108
shares
|
$63.4 Million
0.0% of portfolio
|
Q2 2025
Added 2.83%
|
|
|
Abingworth LLP
London, X0 |
Feb 10, 2023 Q4 2022 |
2,960,231
shares
|
$62.6 Million
19.0% of portfolio
|
Q2 2021
New holding
|
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
2,793,987
shares
|
$59.1 Million
4.47% of portfolio
|
Q4 2023
Added 24.09%
|
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
2,608,372
shares
|
$55.1 Million
0.35% of portfolio
|
Q2 2025
Added 160.62%
|
|
|
Eversept Partners, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
2,383,055
shares
|
$50.4 Million
5.65% of portfolio
|
Q2 2025
Added 25.5%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
2,238,252
shares
|
$47.3 Million
0.0% of portfolio
|
Q2 2025
Added 407.9%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
2,017,683
shares
|
$42.7 Million
0.0% of portfolio
|
Q2 2025
Reduced 3.14%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
1,350,000
shares
|
$28.5 Million
1.9% of portfolio
|
Q2 2025
Added 800.0%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,294,958
shares
|
$27.4 Million
0.0% of portfolio
|
Q2 2025
Added 7.66%
|
|
|
Integral Health Asset Management, LLC
|
Aug 14, 2025 Q2 2025 |
1,150,000
shares
|
$24.3 Million
2.74% of portfolio
|
Q4 2024
Added 130.0%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
919,352
shares
|
$19.4 Million
0.02% of portfolio
|
Q2 2023
New holding
|
|
|
Commodore Capital LP
New York, NY |
Aug 14, 2025 Q2 2025 |
800,000
shares
|
$16.9 Million
1.76% of portfolio
|
Q2 2025
Reduced 68.77%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Aug 13, 2025 Q2 2025 |
772,814
shares
|
$16.3 Million
0.02% of portfolio
|
Q2 2025
Reduced 8.03%
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
758,355
shares
|
$16 Million
3.53% of portfolio
|
Q3 2023
Reduced 22.24%
|
|
|
American Century Companies Inc
Kansas City, MO |
Aug 12, 2025 Q2 2025 |
714,428
shares
|
$15.1 Million
0.01% of portfolio
|
Q2 2025
Added 89.28%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
617,396
shares
|
$13.1 Million
0.99% of portfolio
|
Q2 2025
Added 18.55%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Aug 12, 2025 Q2 2025 |
605,013
shares
|
$12.8 Million
0.01% of portfolio
|
Q2 2025
Reduced 32.24%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Aug 14, 2025 Q2 2025 |
563,075
shares
|
$11.9 Million
2.6% of portfolio
|
Q2 2025
Added 35.45%
|
|
|
First Light Asset Management, LLC
Edina, MN |
Aug 14, 2025 Q2 2025 |
562,981
shares
|
$11.9 Million
2.04% of portfolio
|
Q2 2025
Reduced 52.12%
|